Feasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate-Supplementation for Cell Therapy against Stroke

<div>MRI and histological analysis of pig’s brain with SPIO-labeled hBMSC injection. (a) shows the photomicrographs of the cultured SPIO-hBMSCs after Turnbull’s Blue staining (blue: SPIO). Scale bars: 50 <i>μ</i>m. (b) represents QSM MR images. Arrowheads indicate the signal extinctions caused by the bolus of SPIO-labeled hBMSCs in the left striatum. (c) and (d) display representative photomicrographs of the region around the SPIO-hBMSC injection after Turnbull’s Blue staining (blue: SPIO, (c)) and fluorescence immunostaining (red: MAB1281, (d)). Scale bars: 20 <i>μ</i>m (c) and 50 <i>μ</i>m (d).</div>

Stem Cells International

fig6

Figure 6

Figure 6: Feasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate-Supplementation for Cell Therapy against Stroke 

Figure 6 | Feasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate-Supplementation for Cell Therapy against Stroke 